Abstract: The use of polystyrene-containing polymers as filter aids and/or stabilizers for the filtration or stabilization of aqueous liquids, and also novel particulate polymers which are insoluble in water and scarcely swellable are claimed.

Abstract: The invention relates to excipients in powder form for use in solid pharmaceutical presentations, comprising a pharmaceutically acceptable polymer and a liquid or semisolid solubilizing surface-active substance.

Abstract: The use of copolymers obtainable by the radically initiated polymerization of A) 50 to 99.9 wt % of an olefinically unsaturated C3 to C5 monocarboxylic acid, an olefinically unsaturated C4 to C8 dicarboxylic acid or its anhydride, or a mixture of such carboxylic acids or carboxylic acid anhydrides with B) 0.1 to 50 wt % of one or more long-chained compounds with isolated multiple C—C bonds from the group (1) mono or polyunsaturated C8 to C30 monocarboxylic acids which may have additional hydroxyl groups and their alkaline metal and earth alkaline metal salts, alkyl esters, amides, sorbitane esters, glycerin esters and polyglycerin esters, (2) mono or polyunsaturated aliphatic Ca to C30 amines, (3) mono or polyunsaturated C8 to C30 alcohols and esters thereof with saturated Cl to C4 monocarboxylic acids, (4) to (C8 to C30 alkyl) vinyl ether which may incorporate up to 25 alkylene oxide units, and (5) final and medium-position Ci3 to C30 alkenes; C) 0 to 49.

Abstract: The invention relates to the use of at least one copolymer obtainable by (i) free-radically initiated copolymerization of a monomer mixture comprising (a) 1 to 99.99% by weight of at least one monomer chosen from N-vinylimidazoles and diallylamines optionally in partially or completely quaternized form; (b) 0 to 98.99% by weight of at least one neutral or basic water-soluble monomer which is different form (a); (c) 0 to 50% by weight of at least one unsaturated acid or unsaturated anhydride, (d) 0 to 50% by weight of at least one free-radically copolymerizable monomer which is different from (a), (b) or (c); and (e) 0.01 to 10% by weight of at least one monomer which acts as crosslinker and has at least two ethylenically unsaturated, nonconjugated double bonds; and (ii) subsequent partial or complete quaternization or protonation of the polymer in the case where the monomer (a) is unquaternized or only partially quaternized, as additive for skin cosmetic and dermatological preparations.

Abstract: Solid dosage forms containing at least one polymer binder, at least one active ingredient and, where appropriate, conventional additives, wherein a physiologically tolerated, water-swellable graft copolymer or a mixture of graft copolymers is employed as polymeric binder.

Abstract: The present invention relates to the use of copolymers A containing a) from 50 to 99% by weight of at least one N-vinyllactam or N-vinylamine selected from the group consisting of N-vinylpyrrolidone, N-vinylpiperidone, N-vinylcaprolactam, N-vinylimidazole, methylated N-vinylimidazole, and N-vinylformamide, and b) from 1 to 50% by weight of at least one monomer selected from the group consisting of b1) C8-C30-alkyl esters of monoethylenically unsaturated C3-C8 carboxylic acids; b2) N—C8-C30-alkyl-substituted amides of monoethylenically unsaturated C3-C8 carboxylic acids; b3) N,N—C8-C30-dialkyl-substituted amides of monoethylenically unsaturated C3-C8 carboxylic acids; b4) vinyl esters of aliphatic C8-C30 carboxylic acids; and b5) C8-C30-alkyl vinyl ethers to produce membranes.

Abstract: The present invention relates to quaternized polyamidoamines which have at least one structural unit of the formula VII in which R1, R2, R4 are straight-chain or branched organic radicals optionally containing heteroatoms; R5 is hydrogen or alkyl, R7 is hydrogen or alkyl or two radicals R7 together form a radical having a meaning given for R4, b is an integer from 0 to 50, and c is an integer from 1 to 50. The invention also relates to the preparation of the quaternary polyamidoamines, to compositions which comprise these compounds, and to the use thereof for cosmetic and pharmaceutical purposes, and in the fields of crop protection and textile dyeing. The present invention also relates to the use of quaternized polyamidoamines of the ionene type as biostatic or biocide and thus also biocidal compositions based on quaternized polyamidoamines.

Abstract: The present invention relates to water-soluble or water-dispersible copolymers obtainable by free-radical polymerization of a) 80 to 20% by weight of hydroxy-C1–C6-alkyl (meth)acrylate and, where appropriate, one or more compounds of the formula (A) or (B) with R1=H, C1–C6-alkyl, R2=H, CH3 R3=C1–C24-alkyl or mixtures thereof in the presence of b) 20 to 80% by weight of polyvinyl alcohol (PVA) and c) where appropriate 0 to 20% by weight of other polymerizable compounds (C), a process for their preparation, and their use as coating agent, binder and/or film-forming excipient in pharmaceutical dosage forms.

Abstract: A process for producing solid dosage forms by mixing at least one polymer binder, at least one active ingredient and, where appropriate, conventional additives to form a plastic mixture, and shaping, wherein a physiologically tolerated, water-swellable graft copolymer or a mixture of graft copolymers is employed as polymeric binder.

Abstract: Cationic polyurethanes and polyureas formed from (a) at least one diisocyanate or reaction product thereof with one or more compounds containing two or more active hydrogen atoms per molecule, and (b) at least one diol, primary or secondary amino alcohol, primary or secondary diamine or primary or secondary triamine each with one or more tertiary, quaternary or protonated tertiary amine nitrogen atoms and having a glass transition temperature of at least 25° C. and an amine number of from 50 to 200, based on the non-quaternized or -protonated compounds, or other salts of these polyurethanes and polyureas, are useful as ingredients of cosmetic and pharmaceutical preparations.

Abstract: The use of polymers obtainable by free-radical polymerization of a) at least one vinyl ester of C1–C24-carboxylic acids in the presence of b) polyether-containing compounds and c) optionally one or more other copolymerizable monomers and subsequent at least partial hydrolysis of the ester functions of the original monomers a), in hair cosmetic formulations.

Abstract: Compositions comprising at least one water-insoluble ingredient and at least one copolymer of A) from 5 to 99% by weight of at least one N-vinylcarboxamide of the formula I where R1 and R2 independently of one another are hydrogen or C1-C6-alkyl; B) from 1 to 95% by weight of at least one monomer having a hydrophobic radical which can be copolymerized with vinylcarboxamides of the formula I; and optionally C) from 0 to 94% by weight of at least one other copolymerizable monomer, and the use of the above copolymers as solubility promoters.

Abstract: A cosmetic composition comprising at least one water-soluble or water-dispersible polymer which comprises, in copolymerized form, a) at least one ?,?-ethylenically unsaturated monomer of the formula I in which R1 is hydrogen or C1-C8-alkyl, and X1 is O or NR2, where R2 is hydrogen, C1-C8-alkyl or if C5-C8-cycloalkyl, b) at least one ?,?-ethylenically unsaturated mono- and/or dicarboxylic acid, c) at least one compound having at least one ?,?-ethylenically unsaturated double bond and at least 5 alkylene oxide units per molecule, d) at least one compound having at least one ?,?-ethylenically unsaturated double bond and at least one straight-chain or branched C8-C30-alkyl or -alkylene radical per molecule, where the components c) and/or d) can be partially or completely replaced by a component e), where e) is at least one compound having at least one ?,?-ethylenically unsaturated double bond, at least 5 alkylene oxide units and at least one straight-chain or branched C8-C30-alkyl or -alkylene radical pe

Abstract: The present invention relates to the use of copolymers A containing a) from 50 to 99% by weight of at least one N-vinyllactam or N-vinylamine selected from the group consisting of N-vinylpyrrolidone, N-vinylpiperidone, N-vinylcaprolactam, N-vinylimidazole, methylated N-vinylimidazole, and N-vinylformamide, and b) from 1 to 50% by weight of at least one monomer selected from the group consisting of b1) C8-C30-alkyl esters of monoethylenically unsaturated C3-C8 carboxylic acids; b2) N—C8-C30-alkyl-substituted amides of monoethylenically unsaturated C3-C8 carboxylic acids; b3) N,N—C8-C30-dialkyl-substituted amides of monoethylenically unsaturated C3-C8 carboxylic acids; b4) vinyl esters of aliphatic C8-C30 carboxylic acids; and b5) C8-C30-alkyl vinyl ethers to produce membranes.

Abstract: A process for producing solid dosage forms by mixing at least one polymer binder, at least one active ingredient and, where appropriate, conventional additives to form a plastic mixture, and shaping, wherein a physiologically tolerated, water-swellable graft copolymer or a mixture of graft copolymers is employed as polymeric binder.

Abstract: Graft polymers are used as gas hydrate inhibitors.

Abstract: The present invention relates to quaternized polyamidoamines which have at least one structural unit of the formula VII 1

Abstract: The present invention relates to polymers, polyureas and water-soluble or water-dispersible polymeric salts, a cosmetic or pharmaceutical composition which comprises at least one such polymer, and to the use of the polymers.

Abstract: The present invention relates to crosslinked, water-soluble or water-dispersible polyurethanes of A) at least one water-soluble or water-dispersible polyurethane prepolymer having terminal isocyanate groups of a) at least one compound having a molecular weight in the range from 56 to 300 which contains two active hydrogen atoms per molecule, b) at least one polymer containing two active hydrogen atoms per molecule, c) at least one compound which contains two active hydrogen atoms and at least one ionogenic or ionic group per molecule, d) at least one diisocyanate, B) at least one polymer containing groups which are reactive toward isocyanate groups, chosen from hydroxyl, and primary and secondary amino and/or carboxyl groups, or the salts thereof.

Abstract: The present invention relates to crosslinked, water-soluble or water-dispersible polyurethanes of A) at least one water-soluble or water-dispersible polyurethane prepolymer having terminal isocyanate groups of a) at least one compound having a molecular weight in the range from 56 to 300 which contains two active hydrogen atoms per molecule, b) at least one polymer containing two active hydrogen atoms per molecule, c) at least one compound which contains two active hydrogen atoms and at least one ionogenic or ionic group per molecule, d) at least one diisocyanate, B) at least one polymer containing groups which are reactive toward isocyanate groups, chosen from hydroxyl, and primary and secondary amino and/or carboxyl groups, or the salts thereof.